tiprankstipranks
Alnylam Pharmaceuticals (DE:DUL)
FRANKFURT:DUL
Germany Market

Alnylam Pharma (DUL) Technical Analysis

Compare
1 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
3Neutral
13Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Alnylam Pharmaceuticals’s (DUL) Moving Averages Convergence Divergence (MACD) indicator is -6.28, suggesting Alnylam Pharmaceuticals is a Buy.
Alnylam Pharmaceuticals’s (DUL) 20-Day exponential moving average is 236.25, while Alnylam Pharmaceuticals’s (DUL) share price is €223.1, making it a Sell.
Alnylam Pharmaceuticals’s (DUL) 50-Day exponential moving average is 241.13, while Alnylam Pharmaceuticals’s (DUL) share price is €223.1, making it a Sell.

Alnylam Pharma (DUL) Pivot Points

Mar 12, 2025, 03:24 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
227.80
227.80
227.80
227.80
227.80
227.80
227.80
Fibonacci
227.80
227.80
227.80
227.80
227.80
227.80
227.80
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Alnylam Pharma (DUL) Moving Averages

Mar 12, 2025, 03:24 PM
Period
Simple
Exponential
MA5
227.68Sell
227.31Sell
MA10
229.97Sell
230.63Sell
MA20
237.98Sell
236.25Sell
MA50
242.88Sell
241.13Sell
MA100
243.99Sell
238.80Sell
MA200
231.85Sell
219.73Buy
Alnylam Pharmaceuticals’s (DUL) 10-Day exponential moving average is 230.63, while Alnylam Pharmaceuticals’s (DUL) share price is €223.1, making it a Sell.
Alnylam Pharmaceuticals’s (DUL) 100-Day exponential moving average is 238.80, while Alnylam Pharmaceuticals’s (DUL) share price is €223.1, making it a Sell.
Alnylam Pharmaceuticals’s (DUL) stock price is €223.1 and Alnylam Pharmaceuticals’s (DUL) 50-day simple moving average is 242.88, creating a Sell signal.
Alnylam Pharmaceuticals’s (DUL) stock price is €223.1 and Alnylam Pharmaceuticals’s (DUL) 100-day simple moving average is 243.99, creating a Sell signal.
Alnylam Pharmaceuticals’s (DUL) stock price is €223.1 and Alnylam Pharmaceuticals’s (DUL) 200-day simple moving average is 231.85, creating a Sell signal.

Alnylam Pharma (DUL) Technical Indicators

Mar 12, 2025, 03:24 PM
Name
Value
Implied Action
RSI (14)
33.77
Neutral
STOCH (9,6)
15.84
Buy
STOCHRSI (14)
9.71
Buy
MACD (12,26)
-6.28
Buy
ADX (14)
24.59
Neutral
Williams %R
-100.00
Buy
CCI (14)
-122.93
Buy
ATR (14)
3.83
-
Ultimate Oscillator
35.23
Neutral
ROC
-8.53
Sell
Alnylam Pharmaceuticals’s (DUL) Relative Strength Index (RSI) is 33.77, creating a Neutral signal.
Alnylam Pharmaceuticals’s (DUL) Trend Strength Indicator (ADX) is 24.59, creating a Neutral signal.
Alnylam Pharmaceuticals’s (DUL) Commodity Channel Index (CCI) is -122.93, creating a Buy signal.
Alnylam Pharmaceuticals’s (DUL) Price Rate of Change (ROC) is -8.53, creating a Sell signal.

FAQ

Is DUL a Buy, Hold, or Sell?
Based on DUL’s technical indicators, DUL is a Sell.
    What is DUL’s RSI (14)?
    DUL’s RSI (14) is 33.77, which suggests DUL is a Neutral.
      What is DUL’s MACD?
      DUL’s MACD is -6.28, which suggests DUL is a Buy.
        What is DUL’s 5-day moving average?
        DUL’s 5-day moving average is 227.68, which suggests DUL is a Sell.
          What is DUL’s 20-day moving average?
          DUL 20-day moving average is 237.98, which suggests DUL is a Sell.
            What is DUL’s 50-day moving average?
            DUL’s 50-day moving average is 242.88, which suggests DUL is a Sell.
              What is DUL’s 200-day moving average?
              DUL’s 200-day moving average is 231.85, which suggests DUL is a Sell.
                What is DUL’s Williams % R (14)?
                DUL’s Williams % R (14) is -100.00, which suggests DUL is a Buy.
                  What is DUL’s CCI (14)?
                  DUL’s CCI (14) is -122.93, which suggests DUL is a Buy.
                    What is the share price of Alnylam Pharmaceuticals?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis